| 1 day | +3.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 01/01/2025 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 04/03/2020 |
| Director/Board Member | 45 | 04/03/2020 | |
Axel Rebien
BRD | Director/Board Member | 55 | 01/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/25 | Sell | Chairman | 1,315 | 0.0110% | ||
| 11/08/25 | Sell | Chairman | 39,678 | 0.3306% | ||
| 08/08/25 | Sell | Chairman | 873 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.13% | +3.13% | - | - | 447M | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.53% | +1.09% | +28.65% | +52.33% | 408.71B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
Employees
98
Sector
Pharmaceuticals
